GB201107176D0 - Pyrrolnitrin derivatives - Google Patents

Pyrrolnitrin derivatives

Info

Publication number
GB201107176D0
GB201107176D0 GBGB1107176.8A GB201107176A GB201107176D0 GB 201107176 D0 GB201107176 D0 GB 201107176D0 GB 201107176 A GB201107176 A GB 201107176A GB 201107176 D0 GB201107176 D0 GB 201107176D0
Authority
GB
United Kingdom
Prior art keywords
pyrrolnitrin
derivatives
pyrrolnitrin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1107176.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CXR Biosciences Ltd
Original Assignee
CXR Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CXR Biosciences Ltd filed Critical CXR Biosciences Ltd
Priority to GBGB1107176.8A priority Critical patent/GB201107176D0/en
Publication of GB201107176D0 publication Critical patent/GB201107176D0/en
Priority to PCT/GB2012/050937 priority patent/WO2012146936A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GBGB1107176.8A 2011-04-28 2011-04-28 Pyrrolnitrin derivatives Ceased GB201107176D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1107176.8A GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives
PCT/GB2012/050937 WO2012146936A1 (en) 2011-04-28 2012-04-27 Pyrrolnitrin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1107176.8A GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives

Publications (1)

Publication Number Publication Date
GB201107176D0 true GB201107176D0 (en) 2011-06-15

Family

ID=44202940

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1107176.8A Ceased GB201107176D0 (en) 2011-04-28 2011-04-28 Pyrrolnitrin derivatives

Country Status (2)

Country Link
GB (1) GB201107176D0 (en)
WO (1) WO2012146936A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
TWI638802B (en) 2012-05-24 2018-10-21 芬蘭商奧利安公司 Catechol o-methyltransferase activity inhibiting compounds
CA2897200C (en) 2013-01-14 2021-07-06 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
MX2015009057A (en) 2013-01-15 2015-10-05 Incyte Corp Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors.
EA201690458A1 (en) 2013-08-23 2016-07-29 Инсайт Корпорейшн FURO- AND THYENOPYRIDINCARBOXAMIDES USED AS PIM-KINASE INHIBITORS
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
CN104803914B (en) * 2015-03-05 2017-11-14 成都理工大学 Hexahydro azatropylidene oxybenzamide class compound as Rho kinase inhibitors
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
CN112933094A (en) * 2015-06-18 2021-06-11 听治疗有限责任公司 Methods and compositions for preventing and treating hearing loss
AR105967A1 (en) 2015-09-09 2017-11-29 Incyte Corp SALTS OF A PIM QUINASA INHIBITOR
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
BR112019014593A2 (en) 2017-01-17 2020-02-18 Heparegenix Gmbh MKK4 INHIBITOR AND THE PHARMACEUTICALLY ACCEPTABLE OPTICAL SALES, SOLVATES AND ISOMERS OF THE SAME, COMPOUND AND THE PHARMACEUTICALLY ACCEPTABLE PHARMACEUTICALLY ACCEPTABLE INITIATIVE KNOWLEDGE PROTECTION IN THE PROTEIN OF THE KNOWLEDGE
US10596161B2 (en) 2017-12-08 2020-03-24 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
WO2020049208A1 (en) * 2018-09-09 2020-03-12 Fundacio Privada Institut De Recerca De La Sida - Caixa Aurora kinase as target for treating, preventing or curing hiv infection or aids
CN110327465B (en) * 2019-07-06 2021-12-14 五邑大学 Compound anti-prostatic cancer medicine
CN110974828B (en) * 2019-12-24 2023-03-31 苏州大学 Application of compound Axitinib in preparation of medicine for treating cerebrovascular diseases and pharmaceutical composition of compound Axitinib
CN115611927A (en) * 2020-01-06 2023-01-17 刘力 New compound of vinca antitumor drug
WO2021194919A1 (en) * 2020-03-23 2021-09-30 The Board Of Regents Of The University Of Texas System Combination therapeutics using tumor treating fields (ttfields)
US11857551B1 (en) 2020-07-10 2024-01-02 Ting Therapeutics Llc Methods for the prevention and treatment of hearing loss
JP2024508794A (en) 2021-02-19 2024-02-28 スドー バイオサイエンシーズ リミテッド TYK2 inhibitors and their uses
WO2023056295A1 (en) * 2021-09-30 2023-04-06 Regeneron Pharmaceuticals, Inc. Treatment of glaucoma with rho guanine nucleotide exchange factor 12 (arhgef12) inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3065499D1 (en) 1979-04-11 1983-12-15 Mitsui Petrochemical Ind Process for producing spherical carrier particles for olefin polymerisation catalyst, catalyst comprising such carrier particles, and use of such catalyst in olefin polymerisation
JPH07147016A (en) 1993-11-24 1995-06-06 Matsushita Electric Ind Co Ltd In-line sputtering device
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
EP1057485B1 (en) * 1998-01-14 2005-05-11 Nippon Shinyaku Co., Ltd. Potassium channel activators
KR100704704B1 (en) 1999-03-25 2007-04-09 미쯔비시 웰 파마 가부시키가이샤 Preventives/Remedies for interstitial pneumonia and pulmonary fibrosis
AU5250400A (en) 1999-06-18 2001-01-09 Mitsubishi Pharma Corporation Osteogenesis promoters
WO2002089750A2 (en) * 2001-01-19 2002-11-14 Advanced Photodynamic Technologies, Inc. Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
US20080220103A1 (en) * 2005-10-24 2008-09-11 Jay Birnbaum Method for treating/controlling/killing fungi and bacteria on living animals
CA2705815A1 (en) * 2007-11-17 2009-05-22 Bayer Consumer Care Ag Topical drugs for use in antifungal therapy
EP2571499A1 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Pharmaceutical composition comprising n- acetylcysteine and a xanthine

Also Published As

Publication number Publication date
WO2012146936A1 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
HRP20180646T1 (en) Dispiropyrrolidine derivative
GB201107176D0 (en) Pyrrolnitrin derivatives
HK1203196A1 (en) Substituted benzylpyrazoles
ZA201401884B (en) New dihydroquinoline-2-one derivatives
IL247640B (en) Heteroarylpiperidine derivatives
EP2563129A4 (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
IL231950B (en) Aryl-quinoline derivatives
HK1191653A1 (en) C-glycoside derivatives c-
EP2721029A4 (en) Imidazopyridin-2-one derivatives
ZA201402453B (en) Insecticidal 2-methoxybenzamide derivatives
EP2687531A4 (en) Tetrahydrocarboline derivative
EP2740730A4 (en) Dibenzooxepin derivative
EP2688580A4 (en) Vancomycin derivatives
IL233001A0 (en) Novel iso-ergoline derivatives
GB2490849B (en) Di-aspirin derivatives
SI2766342T1 (en) Phenyl-guanidine derivatives
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
HK1198829A1 (en) Pesticidal diaryl - heterocyclyl derivatives
AU4553P (en) WES04 Westringia fruticosa
GB201115238D0 (en) Pit-stop easy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)